96
Views
8
CrossRef citations to date
0
Altmetric
Original Research

A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice

, , , , , & show all
Pages 999-1005 | Published online: 28 Dec 2022

References

  • AmbrosioniELeonettiGPessinaACPatterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive TherapyJ Hypertens2000181691911081785
  • BangLMChapmanTMGoaKLLercanidipine: a review of its efficacy in the management of hypertensionDrugs20036324497214609358
  • BasileJThe role of existing and newer calcium channel blockers in the treatment of hypertensionJ Clin Hypertens2004662129
  • BeckeyCLundyALutfiNLercanidipine in the treatment of hypertensionAnn Pharmacother2007414657317341540
  • BlackDMBrandRJGreenlickMCompliance to treatment for hypertension in elderly patients: The SHEP pilot studyJ Gerontol19874255273624815
  • BloomsBSContinuation of initial antihypertensive medication after 1-year of therapyClin Ther199820671819737827
  • BorghiCDormiAD’AddatoSBrisighella Heart Study Working Party. 2004. Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart StudyJ Hypertens20042217071615311098
  • BorghiCLercanidipine in hypertensionVasc Health Risk Manag200511738217319103
  • BurnierMMedication adherence and persistence as the cornerstone of effective antihypertensive therapyAm J Hypertens2006191190617070434
  • DavidDSCompliance with hypertensive therapyHypertension200648E1616908756
  • ErdineSAriOZanchettiAESH-ESC guidelines for the management of hypertensionHerz200631331816810473
  • ESH-ESCEuropean Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines CommitteeJ Hypertens20032110115312777938
  • FujitaTShimamotoKWuZWhat are the major challenges in getting patients to the optimal BP goal? Difficulties in educating doctors and patientsInt J Clin Pract Suppl2006150202
  • GrimmRHJrGranditsGACutlerJARelationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension StudyArch Intern Med1997157638489080918
  • JNC VIIThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034212065214656957
  • JonesJKGorkinLLianJFDiscontinuation or and changes in treatment after start or new courses or antihypertensive drugs: a study or a United Kingdom populationBMJ199531129357633238
  • McCombsISNicholMBNewmanCMThe costs or interrupting antihypertensive drug therapy in a Medicaid PopulationMed Care199432214268145599
  • MesserliFHCalcium antagonists in hypertension: from hemodynamics to outcomesAm J Hypertens20021594S97S12121012
  • MonaneMBohnRLGurwitzJHThe effects or initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population based study in the elderlyAm J Hypertens1997106977049234822
  • OkanoGJRascatiKLWilsonJPPatterns or antihypertensive use among patients in the US Department or Defence database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blockerClin Ther1997191433449444451
  • PoluzziEStrahinjaPVargiuAInitial treatment of hypertension and adherence to therapy in general practice in ItalyEur J Clin Pharmacol200561603916082539
  • SHEP Cooperative Research GroupPrevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)JAMA19912653255642046107
  • StaessenJALiYThijsLBlood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trialsHypertens Res20052838540716156503
  • Wolf-MaierKCooperRSKramerHHypertension treatment and control in five European countries, Canada, and the United StatesHypertension200443101714638619